Attached files

file filename
8-K - 8-K - VANGUARD HEALTH SYSTEMS INCa8-k093012.htm
EX-99.1 - EXHIBIT 99.1 - VANGUARD HEALTH SYSTEMS INCexhibit991093012.htm
EX-99.3 - EXHIBIT 99.3 - VANGUARD HEALTH SYSTEMS INCexhibit993093012.htm


EXHIBIT 99.2

VANGUARD HEALTH SYSTEMS, INC.
Supplementary Financial Information

Adjusted EBITDA Margin
Presentation of Most Directly Comparable GAAP Financial Measure (Net Income (Loss) Attributable to Vanguard
Health Systems, Inc. Stockholders Margin) and Reconciliation of Adjusted EBITDA Margin to Net Income (Loss) Attributable to Vanguard Health Systems, Inc. Stockholders Margin

($ presented in millions, unaudited)
Quarter ended
 
September 30,
 
2011
 
2012
Adjusted EBITDA
$
118.7

 
$
133.2

Total revenues
1,436.3

 
1,470.7

Adjusted EBITDA Margin
8.3
 %
 
9.1
%
 
 
 
 
Adjusted EBITDA
$
118.7

 
$
133.2

Interest, net
(45.8
)
 
(50.8
)
Income tax benefit (expense)
15.2

 
(4.9
)
Depreciation and amortization
(62.6
)
 
(65.6
)
Non-controlling interests
2.3

 
(1.0
)
Gain on disposal of assets
1.2

 
0.9

Equity method income
0.1

 
0.6

Stock compensation
(0.7
)
 
(2.2
)
Realized losses on investments

 
(0.2
)
Acquisition related expenses
(12.2
)
 

Debt extinguishment costs
(38.9
)
 

Impairment and restructuring charges
0.1

 

Pension credits
1.0

 
3.8

Discontinued operations, net of taxes
(0.1
)
 
0.1

Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
(21.7
)
 
$
13.9

Total revenues
$
1,436.3

 
$
1,470.7

Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders margin
(1.5
)%
 
0.9
%